Arimoclomol regulatory update

FDA granted Orphan Drug designation to arimoclomol to treat amyotrophic lateral sclerosis (ALS). The hydroxylamine derivative was acquired from Biorex Research and Development Co. (Veszprem-Szabadsagp...